Drug profile · INN
norelgestromin
EVRA
norelgestromin (EVRA) is a progesterone receptor agonist.
EMA: approved Genito-urinary system and sex hormones (G03) G03AA13
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — norelgestromin
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
norelgestromin (EVRA) is a progesterone receptor agonist.
Key facts
INN norelgestromin
Brand EVRA
Mechanism Progesterone receptor agonist
Target Progesterone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03AA13
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is norelgestromin?
norelgestromin (EVRA) is a progesterone receptor agonist.
What is the brand name for norelgestromin?
EVRA is a marketed brand name for norelgestromin. Check FDA Drugs@FDA for the current US label holder and prescribing information.